Cindy Tahl R.'s most recent trade in Fate Therapeutics Inc was a trade of 9,037 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Aug. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fate Therapeutics Inc | Cindy R. Tahl | See Remarks | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 04 Aug 2025 | 9,037 | 397,670 (0%) | 0% | 1.1 | 9,573 | Common Stock |
| Fate Therapeutics Inc | Cindy Tahl R. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Fate Therapeutics Inc | Cindy Tahl R. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 70,000 | 406,707 (0%) | 0% | 0 | Common Stock | |
| Fate Therapeutics Inc | Cindy Tahl R. | See Remarks | Sale of securities on an exchange or to another person at price $ 1.55 per share. | 10 Jan 2025 | 5,654 | 336,707 (0%) | 0% | 1.6 | 8,764 | Common Stock |